TAF11

TAF11 is a peripheral subunit of the general transcription factor TFIID that contributes to RNA Polymerase II preinitiation complex (PIC) assembly across essentially the entire mRNA-coding genome (PMID:28918900). It functions as a histone-fold heterodimer with TAF13, and this TAF11/TAF13 pairing engages the DNA-binding surface of TBP, competing with both TATA-box DNA and the TATA-mimicking N-terminal domain of TAF1 for TBP association (PMID:29111974); heterodimer formation is in turn required for recruitment of both TAFs into TFIID (PMID:28257693). Within the assembling complex TAF11 makes functional contacts that support TBP recruitment and stabilizes the TFIIA-TBP-DNA complex through its histone fold and N-terminal regions (PMID:15657423, PMID:12840001). Despite this, TAF11 contributes little to overall TFIID structural stability, marking it as a regulatory rather than scaffolding subunit (PMID:16895980), and genetic loss of the TAF11-TAF13 heterodimer perturbs PIC formation and Pol II recruitment more than TFIID integrity or TBP deposition, indicating plasticity in how PICs assemble (PMID:40491483). Beyond core transcription, TAF11 acts as a coactivator surface that potentiates activation by nuclear receptors and viral transactivators: it relays RXR AF-2 activity in a manner correlating with its TBP interaction (PMID:8670810), binds the ligand-binding domains of VDR and TRalpha in a ligand-reversible manner (PMID:10744685), and directly binds the HTLV-I Tax protein to enhance Tax-dependent transactivation (PMID:9108034). In Drosophila, TAF11 has an unexpected cytoplasmic function distinct from transcription, serving as a structural component of the RISC Loading Complex where its tetramerization promotes Dcr-2/R2D2 assembly and efficient siRNA loading (PMID:26257286). TAF11 has been linked to disease contexts including TAF13-associated intellectual disability and microcephaly through impaired heterodimer formation (PMID:28257693) and craniofacial defects arising from TAF11 overexpression and aberrant repression of CDH1 and CTNND1 (PMID:39727181).

1. 1996 Medium

   Established that TAF11 is not merely a passive TFIID subunit but a functional relay for activator signals, linking it to nuclear receptor coactivation.

   Evidence Transient coexpression and reporter assays in COS and HeLa cells testing RXR AF-2 stimulation

   PMID:8670810

   Open questions at the time

   • Effect correlated with TBP interaction rather than direct TAF11-RXR contact, leaving the mechanistic bridge undefined
   • Reporter-based readout without endogenous gene analysis
2. 1997 Medium

   Demonstrated a direct physical and functional link between TAF11 and a viral transactivator, showing the coactivator role extends to Tax-driven transcription.

   Evidence Reciprocal Co-IP in HeLa cells and in vitro binding with purified proteins plus reporter assays

   PMID:9108034

   Open questions at the time

   • Single lab; structural basis of the Tax-TAF11 interface not resolved
   • Endogenous viral target genes not assayed
3. 1998 Medium

   Identified TAF11 as a substrate of TIF1alpha kinase, raising the possibility of post-translational regulation of TFIID coactivator function.

   Evidence In vitro kinase assay with purified recombinant TIF1alpha and TFIID components

   PMID:9632676

   Open questions at the time

   • Phosphosite on TAF11 not mapped
   • Functional consequence of phosphorylation in cells not established
   • Single in vitro method
4. 2000 Medium

   Refined the nuclear receptor coactivation model by mapping ligand-reversible TAF11 contacts to a defined receptor surface distinct from other TAF interactions.

   Evidence Co-IP with deletion/point mutagenesis mapping of VDR and TRalpha LBDs in COS cells

   PMID:10744685

   Open questions at the time

   • Interaction shown by Co-IP without structural confirmation
   • Physiological consequence on target gene expression untested
5. 2002 Medium

   Delimited the coactivator specificity of TAF11 by showing it is dispensable for STAT2-mediated interferon transcription, distinguishing it from TAF130.

   Evidence Transient coexpression and reporter assays in cells

   PMID:11802163

   Open questions at the time

   • Negative result from a single reporter system
   • Does not exclude roles in other STAT pathways
6. 2003 High

   Established that TAF11, with TAF13, provides critical TBP contacts during PIC assembly, defining its core mechanistic role in transcription initiation.

   Evidence Temperature-sensitive yeast mutants with genome-wide expression profiling and ChIP for TBP recruitment

   PMID:12840001

   Open questions at the time

   • ts-mutant depletion is slow and may permit secondary effects
   • Direct biochemical mechanism of TBP contact not resolved here
7. 2005 High

   Resolved how TAF11 stabilizes the early initiation complex by defining two TAF11 regions that contact TFIIA and remodel TBP-DNA and TFIIA-DNA interactions.

   Evidence Genetic suppressor screen, in vivo transcription assays, and DNA footprinting in yeast

   PMID:15657423

   Open questions at the time

   • Structural detail of the TAF11-TFIIA interface not solved
   • Generality to all promoter classes not tested
8. 2006 Medium

   Classified TAF11 as a peripheral, non-scaffolding TFIID subunit, distinguishing its regulatory function from structural core TAFs.

   Evidence Systematic RNAi of all TFIID subunits with western blot readouts in Drosophila cells

   PMID:16895980

   Open questions at the time

   • Stability readout does not address functional contribution to transcription
   • Single comparative study
9. 2015 High

   Revealed a transcription-independent cytoplasmic function: TAF11 acts as a structural tetramerizing component of the RISC Loading Complex to drive RNAi.

   Evidence Drosophila genetic screen, Co-IP, in vitro RLC reconstitution, siRNA binding/RISC loading assays, and localization imaging

   PMID:26257286

   Open questions at the time

   • Whether this RNAi role is conserved beyond Drosophila is unaddressed
   • Structural basis of the TAF11 tetramer not solved
10. 2017 High

    Provided the structural mechanism by which TAF11/TAF13 regulates TBP, showing the heterodimer occupies TBP's DNA-binding surface and competes with both TATA DNA and TAF1.

    Evidence Crystal structure, cross-linking mass spectrometry, biochemical competition assays, and mutagenesis

    PMID:29111974

    Open questions at the time

    • How the inhibitory heterodimer is displaced to permit promoter DNA binding in vivo is not defined
    • Static structure does not capture assembly dynamics
11. 2017 High

    Demonstrated by acute depletion that TAF11 is required for near-universal mRNA transcription, settling its role as a general rather than promoter-class-specific factor.

    Evidence Degron-mediated rapid depletion with genome-wide nascent transcription measurement in yeast

    PMID:28918900

    Open questions at the time

    • Does not separate direct TFIID requirement from indirect effects
    • Mammalian generality not tested in this system
12. 2017 Medium

    Connected TAF11 heterodimer formation to human disease, showing TAF13 mutations that disrupt the TAF11-TAF13 interface underlie intellectual disability and microcephaly.

    Evidence Reciprocal Co-IP of disease-associated TAF13 mutants in HeLa cells with molecular modeling

    PMID:28257693

    Open questions at the time

    • Co-IP-based; downstream transcriptional consequences of heterodimer loss not measured
    • Causality demonstrated for TAF13 variants rather than TAF11 itself
13. 2019 Medium

    Linked TAF11 to oncogenic enhancer function, showing it is required for EBV super-enhancer activity and MYC expression.

    Evidence Genome-wide CRISPR screen, CRISPR knockout, luciferase reporter, and RT-qPCR in lymphoblastoid cell lines

    PMID:31167905

    Open questions at the time

    • Whether the effect is direct via TFIID at the super-enhancer is not resolved
    • Single cell-line context
14. 2025 Medium

    Showed TAF11 can act as a transcriptional repressor in development, with overexpression downregulating adhesion genes and disrupting neural crest migration.

    Evidence ChIP, EMSA, dual-luciferase reporter, RNA-seq, and zebrafish overexpression model

    PMID:39727181

    Open questions at the time

    • Mechanism of promoter-specific repression by a general TFIID subunit unclear
    • Single in vivo model
15. 2025 Medium

    Challenged the structural model by showing in vivo loss of the Taf11-Taf13 heterodimer minimally affects TFIID integrity and TBP recruitment yet impairs PIC formation and Pol II loading, revealing plasticity in assembly pathways.

    Evidence Taf13 knockout in mice and ESCs with ChIP for TBP and Pol II recruitment and embryoid body assays

    PMID:40491483

    Open questions at the time

    • Apparent tension with crystallographic TBP-regulation model unresolved
    • Mechanism of the residual PIC-formation defect not defined

• How TAF11/TAF13's TBP-occluding configuration is regulated and displaced in vivo to permit promoter engagement, and how a general TFIID subunit achieves the gene-specific activating versus repressing outcomes seen in development and disease, remain unresolved.
• No mechanism connecting the inhibitory structural state to in vivo PIC assembly dynamics
• No model reconciling general transcription requirement with promoter-selective regulatory outcomes